Xiaofang Zheng

Xiaofang Zheng

Auto-generated profile, based on publicly available information

Xiaofang Zheng

School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
FHFujiao Huang
Fujiao Huang
FLFangyan Liu
Fangyan Liu
XZXiaofang Zhen
Xiaofang Zhen
SGShu Gong
Shu Gong
WCWenbi Chen
Wenbi Chen
ZSZhangyong Song
Zhangyong Song
Rhinosinusitis is a common inflammatory disease of the sinonasal mucosa and paranasal sinuses. The pathogenesis of rhinosinusitis involves a variety of factors, including genetics, nasal microbiota status, infection, and environmental influences. Pathogenic microorganisms, including viruses, bacteria, and fungi, have been proven to target the cilia and/or epithelial cells of ciliated airways, which results in the impairment of mucociliary clearance, leading to epithelial cell apoptosis and the loss of epithelial barrier integrity and immune dysregulation, thereby facilitating infection. However, the mechanisms employed by pathogenic microorganisms in rhinosinusitis remain unclear. Therefore, this review describes the types of common pathogenic microorganisms that cause rhinosinusitis, including human rhinovirus, respiratory syncytial virus, Staphylococcus aureus, Pseudomonas aeruginosa, Aspergillus species, etc. The damage of mucosal cilium clearance and epithelial barrier caused by surface proteins or secreted virulence factors are summarized in detail. In addition, the specific inflammatory response, mainly Type 1 immune responses (Th1) and Type 2 immune responses (Th2), induced by the entry of pathogens into the body is discussed. The conventional treatment of infectious sinusitis and emerging treatment methods including nanotechnology are also discussed in order to improve the current understanding of the types of microorganisms that cause rhinosinusitis and to help effectively select surgical and/or therapeutic interventions for precise and personalized treatment.

13 October 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
XHXuemei He
Xuemei He
YMYingyu Mao
Yingyu Mao
DLDuxin Liu
Duxin Liu
XZXiaofang Zheng
Xiaofang Zheng
KSKaibo Song
Kaibo Song
ZSZhangyong Song
Zhangyong Song
Azole-resistant Aspergillus fumigatus poses an increasing clinical challenge. In this study, 22 clinical filamentous fungal isolates from southwestern China were preliminarily identified as A. fumigatus based on morphological characteristics, and their antifungal susceptibility was determined using broth microdilution. Three isolates (AF268, AF275 and AF277) exhibiting high-level voriconazole resistance were selected for further phenotypic and molecular characterization. Compared with AF293, the three resistant isolates showed no significant differences in biofilm metabolic activity or biomass, but all exhibited significantly reduced conidiation at 72 h. In a Galleria mellonella infection model, these isolates exhibited attenuated virulence, as indicated by increased larval survival and reduced fungal burdens. All three isolates harbored the cyp51A TR46/Y121F/T289A genotype and shared Hmg1 S212P/Y564F variants, while no Cyp51B substitutions were detected. RT-qPCR analysis further indicated transcriptional dysregulation of ergosterol biosynthesis- and efflux pump-associated genes. These findings show that the three clinical isolates carrying the canonical cyp51A TR46/Y121F/T289A resistance genotype showed differences in biological traits and transcriptional responses relative to the reference strain AF293. The high voriconazole MICs are consistent with the shared cyp51A genotype, whereas the functional significance of the Hmg1 variants and transcriptional changes requires further genetic validation.